Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162M
-
Number of holders
-
415
-
Total 13F shares, excl. options
-
37.2M
-
Shares change
-
-2.38M
-
Total reported value, excl. options
-
$7.71B
-
Value change
-
-$499M
-
Put/Call ratio
-
1.18
-
Number of buys
-
237
-
Number of sells
-
-151
-
Price
-
$207.31
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q3 2021
523 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q3 2021.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 415 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.2M shares
of 162M outstanding shares and own 22.96% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.8M shares), BlackRock Inc. (4.93M shares), RA CAPITAL MANAGEMENT, L.P. (2.1M shares), STATE STREET CORP (1.75M shares), Capital World Investors (1.48M shares), FMR LLC (1.46M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.37M shares), FRANKLIN RESOURCES INC (1.07M shares), GEODE CAPITAL MANAGEMENT, LLC (957K shares), and MORGAN STANLEY (686K shares).
This table shows the top 415 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.